₹ 25.30
-0.19 (-0.75%)
BSE
B
Beryl Drugs
₹ 25.30
BSE
Beryl Drugs Fundamentals
Company Valuation
Market Cap (₹ Cr.)
13
PE Ratio
20.70
PB Ratio
1.31
Dividend Yield
-
ROE
4.30%
ROCE
8.89%
Book Value (₹)
19.45
Face Value (₹)
10.00
Analyse BERLDRG with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 26.38% | 26.38% | 27.48% | 27.82% | 27.97% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 68.71% | 66.25% | 64.94% | 63.56% | 63.47% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BERLDRG Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
524606
NSE Scrip Name
BERLDRG
ISIN
INE415H01017

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






